Gary V. Doern
Impact in
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
Papers in
-
- Bacterial Identification and Susceptibility Testing 67
-
- Antibiotic Resistance in Bacteria 51
- Co-authors
- Michael A. Pfaller (38 shared papers)Angela B. Brueggemann (28 shared papers)Ronald N. Jones (33 shared papers)Daniel J. Diekema (30 shared papers)Susan E. Beekmann (18 shared papers)Kari C. Kugler (8 shared papers)Kristopher P. Heilmann (20 shared papers)Sandra S. Richter (28 shared papers)
- Journals
- Journal of Clinical Microbiology (69 papers)Diagnostic Microbiology and Infectious Disease (51 papers)Antimicrobial Agents and Chemotherapy (29 papers)Clinical Infectious Diseases (12 papers)European Journal of Clinical Microbiology & Infectious Diseases (7 papers)
- Partner nations
- United StatesBrazilUnited Kingdom
In The Last Decade
Gary V. Doern
249 papers receiving 13.3k citations
Peers
Comparison fields: 5 of 161
- Applied Microbiology and Biotechnology 1.2k
- Molecular Medicine 3.0k
- Clinical Biochemistry 2.9k
- Microbiology 1.7k
- Infectious Diseases 4.4k
Countries citing papers authored by Gary V. Doern
This map shows the geographic impact of Gary V. Doern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary V. Doern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary V. Doern more than expected).
Fields of papers citing papers by Gary V. Doern
This network shows the impact of papers produced by Gary V. Doern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary V. Doern. The network helps show where Gary V. Doern may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary V. Doern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 488 | |
| 2 | 2001 | 483 | |
| 3 | 1996 | 434 | |
| 4 | 2001 | 357 | |
| 5 | 2000 | 348 | |
| 6 | 1998 | 343 | |
| 7 | 2002 | 343 | |
| 8 | 2007 | 332 | |
| 9 | 1994 | 328 | |
| 10 | 2003 | 276 | |
| 11 | 1990 | 268 | |
| 12 | 1996 | 265 | |
| 13 | 2000 | 259 | |
| 14 | 1998 | 252 | |
| 15 | 1999 | 227 | |
| 16 | 1999 | 215 | |
| 17 | 2011 | 207 | |
| 18 | 1998 | 195 | |
| 19 | 2013 | 194 | |
| 20 | 2019 | 192 |
About Gary V. Doern
Gary V. Doern is a scholar working on Clinical Biochemistry, Molecular Medicine, Epidemiology, Microbiology and Infectious Diseases, having authored 251 papers that have together received 14.7k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (78 papers), Bacterial Identification and Susceptibility Testing (67 papers), Antibiotic Resistance in Bacteria (51 papers), Antibiotics Pharmacokinetics and Efficacy (50 papers), Antimicrobial Resistance in Staphylococcus (47 papers), Bacterial Infections and Vaccines (39 papers), Streptococcal Infections and Treatments (26 papers) and Antibiotic Use and Resistance (23 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.2k citations), Molecular Medicine (3.0k citations), Clinical Biochemistry (2.9k citations), Microbiology (1.7k citations) and Infectious Diseases (4.4k citations). Gary V. Doern has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Michael A. Pfaller, Angela B. Brueggemann, Ronald N. Jones, Daniel J. Diekema, Susan E. Beekmann, Kari C. Kugler, Kristopher P. Heilmann, Sandra S. Richter, Stacy L. Coffman and Shawn A. Messer. Their work appears in journals such as Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.